Efficacy of PARPi re-maintenance therapy for recurrent ovarian cancer.
Wang Y, Yang Y, Guo B, Li X, Tuersun R, Cao Y, Li J, Liu J, Li S, Liu T, Huang Y.
Wang Y, et al. Among authors: liu t.
Front Oncol. 2025 Jan 10;14:1512339. doi: 10.3389/fonc.2024.1512339. eCollection 2024.
Front Oncol. 2025.
PMID: 39868369
Free PMC article.